Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.5471 USD
−206.87 M USD
3.90 M USD
76.81 M
About I-MAB
Sector
CEO
Xi-Yong Fu
Headquarters
Rockville
Website
Founded
2016
FIGI
BBG00QQ8DFK6
I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Rockville, MD.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.